•  
  •  
 

Abstract

Indomethacin is a nonsteroidal anti-inflammatory drug useful to reduce pain, rheumatoid arthritis and fever. Indomethacin, a Class II drug characterized by high permeability and low solubility. The goal of study was to develop Indomethacin nanoparticles by nanoprecipitation method and subsequently investigate if this nanoparticle formulation leads to enhanced solubility and a faster dissolution rate. Nine different formulas were prepared by using three different polymers (HPMC E50, PVP- K30, and poloxamer -188) in three different drug: polymer ratio 1:1, 1:2 and 1:3. Different types and concentrations of polymer used in this study, and the results reveal and found to have a significant (p≤ 0.05) effect on Indomethacin nanoparticle size. The selected formulation N2 contain PVP-K30 in drug: polymer ratio 1:1, has a smallest particle size (94.3 nm) and largest surface area 23.6 m2/g. This formula N2 was freeze dried and subjected for further characterized surface morphology by SEM, and compatibility study by FTIR and DSC. The drug content of N2 formulation contain (95.13±0.5%) of Indomethacin nanoparticles, and the dissolution study demonstrated that the optimized formulation N2 achieved 100% dissolution within 50 minutes, compared to only 20% for raw Indomethacin. In summary, Indomethacin nanoparticles formulation is a suitable method for improving the solubility and release profile of it.

References

[1] Imono M, Uchiyama H, Yoshida S, Miyazaki S, Tamura N, Tsutsumimoto H, et al. The elucidation of key factors for oral absorption enhancement of nanocrystal formulations: In vitroein vivo correlation of nanocrystals. Eur J Pharm Biopharm 2020 Jan 1;146:84e92.

[2] Kumari L, Choudhari Y, Patel P, Das Gupta G, Singh D, Rosenholm JM, et al. Advancement in solubilization approaches: a step towards bioavailability enhancement of poorly soluble drugs, 13. United States: Life; 2023. Fig. 7. Dissolution profile of raw Indomethacin and N2 formulation mean ± SEM (n ¼ 3). 106 MA'AEN JOURNAL FOR MEDICAL SCIENCES 2025;4:100e107

[3] Mohamed NA, Abou-Saleh H, Kameno Y, Marei I, de Nucci G, Ahmetaj-Shala B, et al. Studies on metaleorganic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension. Sci Rep 2021 Dec 1;11(1).

[4] Liu Y, Liang Y, Yuhong J, Xin P, Han JL, Zhu R, et al. Advances in nanotechnology for enhancing the solubility and bioavailability of poorly soluble drugs. Drug Des Dev Ther 2024;18:1469e95. Dove Medical Press Ltd.

[5] Amoabediny G, Haghiralsadat F, Naderinezhad S, Helder MN, Akhoundi Kharanaghi E, Mohammadnejad Arough J, et al. Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: A comprehensive review. Intern J Poly Mater Poly Biomat 2018;67:383e400. Taylor and Francis Inc.

[6] Wilson DR, Sen R, Sunshine JC, Pardoll DM, Green JJ, Kim YJ. Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy. Nanomedicine 2018 Feb 1; 14(2):237e46.

[7] An overview of nanoparticles in drug delivery_ Properties and applications - ScienceDirect. [8] Lucas S. The Pharmacology of Indomethacin. Headache 2016 Feb 1;56(2):436e46.

[9] Fu Q, Lu HD, Xie YF, Liu JY, Han Y, Gong NB, et al. Salt formation of two BCS II drugs (indomethacin and naproxen) with (1R, 2R)-1,2-diphenylethylenediamine: Crystal structures, solubility and thermodynamics analysis. J Mol Struct 2019 Jun 5;1185:281e9.

[10] Thrombotic C. Indomethacin Capsules, USP 25 mg Rx only warning: risk of serious cardiovascular and gastrointestinal events [Internet]. Available from: https://www.fda.gov/ drugsatfda.

[11] Rashid AM, Abd-Alhammid SN. Formulation and characterization of itraconazole as nanosuspension dosage form for enhancement of solubility. Iraqi J Pharm Sci 2019 Dec 21; 28(2):124e33.

[12] Alhagiesa AW, Ghareeb MM. Formulation and Characterization of Nimodipine Nanoparticles for the Enhancement of solubility and dissolution rate. Iraqi J Pharm Sci 2021 Dec 9; 30(2):143e52.

[13] Almohamady HI, Mortagi Y, Gad S, Zaitone S, Alshaman R, Alattar A, et al. Spanlastic Nano-Vesicles: A Novel Approach to Improve the Dissolution, Bioavailability, and Pharmacokinetic Behavior of Famotidine. Pharmaceuticals 2024 Dec 1; 17(12).

[14] Xi Z, Zhang W, Fei Y, Cui M, Xie L, Chen L, et al. Evaluation of the solid dispersion system engineered from mesoporous silica and polymers for the poorly water soluble drug indomethacin: In vitro and in vivo. Pharmaceutics 2020 Feb 1; 12(2).

[15] Al-Hajjeh R, Al-Ali H. Application of FTIR Spectroscopy method for The Quantification of Ascorbic Acid in Bulk Materials and Pharmaceutical Formulation. Iraqi J Pharm Sci 2023;32(3):186e94.

[16] Hussien RM, Ghareeb MM. Formulation and Characterization of Isradipine Nanoparticle for Dissolution Enhancement. Iraqi J Pharm Sci 2021;30(1):218e25.

[17] Patidar M, Maheshwari RK, Agrawal S. Solubility enhancement of indomethacin by forming solid dispersion using mixed hydrotropy. Certified Journal │ Patidar et al World J Pharm Res 2022;11(1) [Internet], www.wjpr.net.

[18] Alhagiesa AW, Ghareeb MM. Formulation and Characterization of Nimodipine Nanoparticles for the Enhancement of solubility and dissolution rate. Iraqi J Pharm Sci 2021 Dec 9; 30(2):143e52.

[19] Torre-iglesias P. Enhancement of the Dissolution Rate of Indomethacin by Solid Dispersions in Low-substituted Hydroxypropyl Cellulose [Internet]. Available from: www. ijpsonline.com.

[20] Franco P, De Marco I. The use of poly(N-vinyl pyrrolidone) in the delivery of drugs: a review. Polymers 2020;12:1e29. MDPI AG.

[21] Effects of nanoparticle size, shape, and zeta potential on drug delivery - ScienceDirect. Int J Pharm 2024 Dec 5. https:// doi.org/10.1016/j.ijpharm.2024.124799 [Internet] [cited 2025 Mar 14];666.

[22] Caputo F, Clogston J, Calzolai L, Rosslein M, Prina-Mello A. € Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity. J Contr Release 2019;299: 31e43. Elsevier B.V.

[23] Abd-Alrazaq IF, Rahi FA, Al-Lami MS. Preparation and characterization of Nimesulide nanoparticles for dissolution improvement, 18; 2018. AJPS.

[24] Ozsoysal S, Bilgili E. Non-Traditional Natural Stabilizers in Drug Nanosuspensions. Journal of Pharmaceutical and BioTech Industry 2024 Dec 13;1(1):38e71 [Internet] Available from: https://www.mdpi.com/2813-9380/1/1/5.

[25] Be Sipos IC. Spray-dried indomethacin-loaded polymeric micelles for the improvement of intestinal drug release and permeability. Euroencespean J Pharm Sci 2022 Jul;174:1e11.

[26] Joshi K, Chandra A, Jain K, Talegaonkar S. Nanocrystalization: an emerging technology to enhance the bioavailability of poorly soluble drugs. Pharm Nanotechnol 2019 Apr 9;7(4):259e78.

[27] Khan J, Bashir S, Khan MA, Naz A. Smart nanocrystal of indomethacin: Nanonization and characterization through top down method of media milling. Article Pakistan J Pharm Sci 2020;33:765e70 [Internet] Available from: https://www. researchgate.net/publication/344078444.

[28] Colombo M, Minussi C, Orthmann S, Staufenbiel S, Bodmeier R. Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility. Eur J Pharm Biopharm 2018 Apr 1;125:159e68.

[29] Alzalzalee RA, Kassab HJ. Factors affecting the preparation of cilnidipine nanoparticles. Iraqi J Pharm Sci 2023;32:235e43.

Download

Share

COinS